Literature DB >> 15662823

Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors.

Toru Serizawa1, Naokatsu Saeki, Yosmhinori Higuchi, Junichi Ono, Shinji Matsuda, Makoto Sato, Masamichi Yanagisawa, Toshihiko Iuchi, Osamu Nagano, Akira Yamaura.   

Abstract

OBJECT: The authors assessed the diagnostic value of 201Tl Cl single-photon emission computerized tomography (SPECT), performed after gamma knife surgery (GKS) for metastatic brain tumors in differentiating tumor recurrence from radiation injury.
METHODS: Of 6503 metastatic brain tumors treated with GKS, 201Tl SPECT was required in 72 to differentiate between tumor recurrence and radiation injury. When the Tl index was greater than 5, the lesion was diagnosed as a tumor recurrence. When the index was < 3.0 it was called radiation injury. In cases with a Tl index between 3 and 5, 201Tl SPECT was repeated once per month until the Tl index was greater than 5 or less than 3. If the Tl index fluctuated between 3 and 5 for 2 months, the lesion was diagnosed as radiation injury. The final diagnosis was based on histological examination or clinical course. The sensitivity of the method was 91%; thus 201Tl SPECT is effective for differentiating between tumor recurrence and radiation injury in metastatic brain tumors treated with GKS. Caution is necessary, however, for the following reasons: 1) simple interinstitutional comparisons of Tl indices are not possible because measurement methods are institute specific; 2) steroid administration decreases the Tl index to a variable degree; and 3) a severe radiation injury lesion, as is often seen after repeated GKS or very high dose GKS, may have a Tl index greater than 5.
CONCLUSIONS: Used with critical insight 201Tl Cl SPECT can be useful in distinguishing between tumor regrowth and radiation necrosis in patients with cerebral metastases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15662823     DOI: 10.3171/jns.2005.102.s_supplement.0266

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  21 in total

1.  Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery.

Authors:  G Lai; A Mahadevan; D Hackney; P C Warnke; F Nigim; E Kasper; E T Wong; B S Carter; C C Chen
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-01       Impact factor: 3.825

Review 2.  Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review.

Authors:  Sharad Goyal; Ann W Silk; Sibo Tian; Janice Mehnert; Shabbar Danish; Sinthu Ranjan; Howard L Kaufman
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777

3.  Comparison of two-stage Gamma Knife radiosurgery outcomes for large brain metastases among primary cancers.

Authors:  Daisuke Ito; Kyoko Aoyagi; Osamu Nagano; Toru Serizawa; Yasuo Iwadate; Yoshinori Higuchi
Journal:  J Neurooncol       Date:  2020-02-05       Impact factor: 4.130

4.  Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.

Authors:  Francesco Cicone; Giuseppe Minniti; Andrea Romano; Annalisa Papa; Claudia Scaringi; Francesca Tavanti; Alessandro Bozzao; Riccardo Maurizi Enrici; Francesco Scopinaro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-15       Impact factor: 9.236

5.  Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.

Authors:  Abigail L Stockham; Manmeet Ahluwalia; Chandana A Reddy; John H Suh; Aryavarta Kumar; Michael A Vogelbaum; Gene H Barnett; Erin S Murphy; Samuel T Chao
Journal:  J Neurooncol       Date:  2013-09-18       Impact factor: 4.130

6.  Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.

Authors:  Koichi Mitsuya; Yoko Nakasu; Satoshi Horiguchi; Hideyuki Harada; Tetsuo Nishimura; Etsuro Bando; Hiroto Okawa; Yoshihiro Furukawa; Tatsuo Hirai; Masahiro Endo
Journal:  J Neurooncol       Date:  2010-01-08       Impact factor: 4.130

7.  Salvage stereotactic radiosurgery with adjuvant use of bevacizumab for heavily treated recurrent brain metastases: a preliminary report.

Authors:  Shoji Yomo; Motohiro Hayashi
Journal:  J Neurooncol       Date:  2015-11-30       Impact factor: 4.130

Review 8.  Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.

Authors:  Jacob Ruzevick; Lawrence Kleinberg; Daniele Rigamonti
Journal:  Neurosurg Rev       Date:  2013-11-15       Impact factor: 3.042

Review 9.  Radiosurgery for metastatic brain tumors.

Authors:  Toru Serizawa
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

10.  Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence.

Authors:  Friso W A Hoefnagels; Frank J Lagerwaard; Esther Sanchez; Cornelis J A Haasbeek; Dirk L Knol; Ben J Slotman; W Peter Vandertop
Journal:  J Neurol       Date:  2009-03-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.